title: Global health: the ethical responsibility of the pharmaceutical industry.
abstract: Health as a global issue concerns all and clearly manifests global inequality. All stakeholders of the healthcare systems and disease treatment--including the pharmaceutical industry--have an ethical obligation to contribute to promoting global health. At Novo Nordisk we primarily focus on providing our contribution to global health through defeating diabetes. At the same time we stand by being a private company required to deliver a financial profit, which is why we must create positive results on the financial, the environmental and the social bottom lines. In this article we attempt to provide a brief overview of some of the initiatives that we think business companies can take--and therefore are also obliged to in promoting global health. Further, we have pointed out a number of dilemmas within research and development as well as business ethics that all companies face when they convert the ethical principles to daily practice globally.
authors.affiliation: Novo Nordisk, Novo Allé 1, bygning 6B, 2880, Bagsvaerd, Denmark.
authors.forename: Lars Christian
authors.initials: LC
authors.lastname: Lassen
authors.forename: Mads Krogsgaard
authors.initials: MK
authors.lastname: Thomsen